Compare BLCO & RHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | RHP |
|---|---|---|
| Founded | 1853 | 1991 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.8B |
| IPO Year | 2022 | 1991 |
| Metric | BLCO | RHP |
|---|---|---|
| Price | $16.93 | $97.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 12 |
| Target Price | $17.31 | ★ $108.50 |
| AVG Volume (30 Days) | 408.9K | ★ 467.3K |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 4.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.77 |
| Revenue | ★ $4,976,000,000.00 | $2,486,871,000.00 |
| Revenue This Year | $8.08 | $10.19 |
| Revenue Next Year | $5.77 | $8.07 |
| P/E Ratio | ★ N/A | $26.00 |
| Revenue Growth | 6.23 | ★ 6.48 |
| 52 Week Low | $10.45 | $76.27 |
| 52 Week High | $18.99 | $118.03 |
| Indicator | BLCO | RHP |
|---|---|---|
| Relative Strength Index (RSI) | 60.34 | 61.88 |
| Support Level | $16.83 | $91.33 |
| Resistance Level | $17.41 | $99.39 |
| Average True Range (ATR) | 0.44 | 2.12 |
| MACD | 0.04 | 0.43 |
| Stochastic Oscillator | 59.89 | 78.78 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Ryman Hospitality Properties Inc is a lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and country music entertainment experiences. Its core holdings are Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; Gaylord National Resort & Convention Center; and Gaylord Rockies Resort & Convention Center. The company has three business segments: Hospitality, which includes Gaylord Hotels properties, the Inn at Opryland, and the AC Hotel, Entertainment which includes the entertainment and media assets comprising OEG, and Corporate and Other, which includes corporate expenses. It derives the vast majority of its revenue from its Hospitality segment.